In a filing, Edwards Lifesciences Corp revealed its CEO Zovighian Bernard J unloaded Company’s shares for reported $0.43 million on Mar 10 ’25. In the deal valued at $69.51 per share,6,164 shares were sold. As a result of this transaction, Zovighian Bernard J now holds 59,083 shares worth roughly $4.04 million.
Then, Lippis Daniel J. sold 400 shares, generating $27,792 in total proceeds. Upon selling the shares at $69.48, the CVP, JAPAC now owns 22,588 shares.
Before that, Zovighian Bernard J bought 6,164 shares. Edwards Lifesciences Corp shares valued at $428,448 were divested by the Officer at a price of $69.51 per share.
Stifel upgraded its Edwards Lifesciences Corp [EW] rating to a Buy from a a Hold in a research note published on January 30, 2025; the price target was increased to $90 from $75. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in mid January from “a Peer perform” to “an Underperform”. BofA Securities also remained covering EW and has increased its forecast on December 16, 2024 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of EW
On Tuesday, Edwards Lifesciences Corp [NYSE:EW] saw its stock fall -0.20% to $68.39. Over the last five days, the stock has lost -4.19%. Edwards Lifesciences Corp shares have fallen nearly -7.62% since the year began. Nevertheless, the stocks have fallen -27.10% over the past one year. While a 52-week high of $96.12 was reached on 02/14/25, a 52-week low of $58.93 was recorded on 03/11/25. SMA at 50 days reached $72.14, while 200 days put it at $73.69.
Levels Of Support And Resistance For EW Stock
The 24-hour chart illustrates a support level at 67.79, which if violated will result in even more drops to 67.18. On the upside, there is a resistance level at 69.01. A further resistance level may holdings at 69.63. The Relative Strength Index (RSI) on the 14-day chart is 35.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.04%. Stochastics %K at 8.62% indicates the stock is a buying.
